Watch GILD. Know when insiders buy.
One email the day a filing lands. Free.
Work order
44
WATCH · insiders 25, shorts 63
Insiders, 90 days
−$5.6M
net selling · 0 buys, 12 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
5 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $187.5BP/E —DIV YIELD 2.13%FCF YIELD 6.90%REV TTM $30.5B +5.5%NET INCOME −$3.2B −151.3%NET DEBT $20.8B52W 110.56 – 155.80NEXT EARNINGS Oct 29 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $7.8B | +10.2% | 79.8% | −$10.4B | −$10.5B | −635.5% | — | $3.6B | $140M | $3.4B | Aug 6 |
| Q1 2026 · Mar 31 | $7B | +4.4% | 79.2% | $2.6B | $2B | +53.7% | — | $2.5B | $117M | $2.4B | May 7 |
| Q4 2025 · Dec 31derived | $7.9B | +4.7% | 79.5% | $2B | $2.2B | +22.4% | — | $3.3B | $205M | $3.1B | Feb 24 |
| Q3 2025 · Sep 30 | $7.8B | +3.0% | 79.8% | $3.3B | $3.1B | +143.6% | — | $4.1B | $147M | $4B | Nov 7 |
| Q2 2025 · Jun 30 | $7.1B | +1.8% | 78.8% | $2.5B | $2B | +21.4% | — | $827M | $107M | $720M | Aug 6 |
| Q1 2025 · Mar 31 | $6.7B | −0.3% | 76.9% | $2.2B | $1.3B | — | — | $1.8B | $104M | $1.7B | May 7 |
| Q4 2024 · Dec 31derived | $7.6B | +6.4% | 79.1% | $2.5B | $1.8B | +24.8% | — | $3B | $147M | $2.8B | Feb 24 |
| Q3 2024 · Sep 30 | $7.5B | +7.0% | 79.1% | $888M | $1.3B | −42.5% | — | $4.3B | $141M | $4.2B | Nov 7 |
| Q2 2024 · Jun 30 | $7B | — | 77.8% | $2.6B | $1.6B | — | — | $1.3B | $130M | $1.2B | Aug 7 |
| Q1 2024 · Mar 31 | $6.7B | — | 76.8% | −$4.3B | −$4.2B | — | — | $2.2B | $105M | $2.1B | May 7 |
| Q4 2023 · Dec 31derived | $7.1B | — | 70.6% | $1.6B | $1.4B | — | — | $2.2B | $215M | $2B | Feb 24 |
| Q3 2023 · Sep 30 | $7.1B | — | 77.8% | $2.6B | $2.2B | — | — | $1.8B | $122M | $1.6B | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $29.4B | 78.8% | $10B | $8.5B | 28.9% | — | $10B | $563M | $9.5B | $1.9B | $4B |
| FY2024 · to Dec 31 | $28.8B | 78.3% | $1.7B | $480M | 1.7% | — | $10.8B | $523M | $10.3B | $1.1B | $3.9B |
| FY2023 · to Dec 31 | $27.1B | 76.0% | $7.6B | $5.7B | 20.9% | — | $8B | $585M | $7.4B | $1B | $3.8B |
| FY2022 · to Dec 31 | $27.3B | 79.3% | $7.3B | $4.6B | 16.8% | — | $9.1B | $728M | $8.3B | $1.4B | $3.7B |
| FY2021 · to Dec 31 | $27.3B | 75.8% | $9.9B | $6.2B | 22.8% | — | $11.4B | $579M | $10.8B | $546M | $3.6B |
| FY2020 · to Dec 31 | $24.7B | 81.5% | $4.1B | $123M | 0.5% | — | $8.2B | $650M | $7.5B | $1.6B | $3.4B |
Every number comes from GILEAD SCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.